Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Pharvaris N.V.

PHVS · Nasdaq · CIK 0001830487 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

119 Form 4 transaction lines observed in the same window
65 sales · 54 option, withholding, award, gift or other lines

Last qualifying purchaseNo qualifying purchase is present in the local Form 4 history.

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesHigh
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Lu PengPresident
○○○○○▼○○▼○○○
Lesage AnneChief Early Development
○▼○▼○▼▼
Schikan Johannes Gerardus Christiaan PetrusDirector
▼▼▼○▼
Glassman RobertDirector
○▼○▼
Modig BerndtChief Executive Officer
▼▼○
Souverijns WimChief Commercial Officer
○▼▼
● Purchase▼ Sale○ Other

Showing the six most active owners; 4 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot.—

Recent Form 4 activity

0Purchases
68Sales
58Other Form 4 lines
55SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING65 sale line(s) · context only
OTHER54 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
2,007,998
Previous report
1,784,789
Avg daily volume
707,991
Days to cover
2.8

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

No qualifying code P equity purchase is present in the local Form 4 history.

Form 4 evidence

126 transaction lines in the latest 365-day window; 126 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-12Lu PengTax withholding (F)Common Stock117USD 31.10USD 3,639SEC filing ↗
2026-10-11Lu PengTax withholding (F)Common Stock109USD 31.10USD 3,390SEC filing ↗
2026-09-23Monges VivianeSale (S)Common Stock11,969USD 33.05USD 395,575SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-12Lu PengTax withholding (F)Common Stock117USD 31.10USD 3,639SEC filing ↗
2026-10-11Lu PengTax withholding (F)Common Stock109USD 31.10USD 3,390SEC filing ↗
2026-09-23Monges VivianeSale (S)Common Stock11,969USD 33.05USD 395,575SEC filing ↗
2026-09-23Monges VivianeOption exercise / conversion (M)Common Stock11,969USD 8.05USD 96,350SEC filing ↗
2026-09-22Schikan Johannes Gerardus Christiaan PetrusSale (S)Common Stock800USD 36.19USD 28,952SEC filing ↗
2026-09-22Schikan Johannes Gerardus Christiaan PetrusOption exercise / conversion (M)Common Stock800USD 20.00USD 16,000SEC filing ↗
2026-09-22Lu PengOption exercise / conversion (M)Common Stock45,308USD 2.59USD 117,348SEC filing ↗
2026-09-21Nassif David W.Sale (S)Common Stock6,000USD 36.47USD 218,820SEC filing ↗
2026-09-21Nassif David W.Gift (G)Common Stock500USD 0.00USD 0SEC filing ↗
2026-09-17Schikan Johannes Gerardus Christiaan PetrusSale (S)Common Stock200,000USD 35.00USD 7,000,000SEC filing ↗
2026-09-17Modig BerndtOption exercise / conversion (M)Common Stock300,000USD 35.00USD 10,500,000SEC filing ↗
2026-09-17Lu PengSale (S)Common Stock100,000USD 35.00USD 3,500,000SEC filing ↗
2026-09-17Lu PengOption exercise / conversion (M)Common Stock100,000USD 2.59USD 259,000SEC filing ↗
2026-09-17Lesage AnneSale (S)Common Stock20,000USD 38.27USD 765,400SEC filing ↗
2026-09-17Glassman RobertSale (S)Common Stock14,493USD 38.56USD 558,850SEC filing ↗
2026-09-17Glassman RobertOption exercise / conversion (M)Common Stock14,493USD 18.14USD 262,903SEC filing ↗
2026-09-17Bjork ElisabethSale (S)Common Stock52,500USD 37.89USD 1,989,225SEC filing ↗
2026-09-17Bjork ElisabethOption exercise / conversion (M)Common Stock52,500USD 15.64USD 821,100SEC filing ↗
2026-09-15Glassman RobertSale (S)Common Stock8,667USD 38.27USD 331,686SEC filing ↗
2026-09-15Glassman RobertOption exercise / conversion (M)Common Stock8,667USD 22.31USD 193,361SEC filing ↗
2026-09-15Abele Stefan AndreasSale (S)Common Stock46,400USD 38.17USD 1,771,236SEC filing ↗
2026-09-15Abele Stefan AndreasOption exercise / conversion (M)Common Stock45,000USD 16.40USD 738,000SEC filing ↗
2026-09-15Souverijns WimSale (S)Common Stock6,090USD 38.99USD 237,449SEC filing ↗
2026-09-14Souverijns WimSale (S)Common Stock20,000USD 39.31USD 786,200SEC filing ↗
2026-09-14Souverijns WimOption exercise / conversion (M)Common Stock20,000USD 17.43USD 348,600SEC filing ↗
2026-09-14Modig BerndtSale (S)Common Stock2,291USD 39.40USD 90,265SEC filing ↗
2026-09-14Lu PengTax withholding (F)Common Stock117USD 38.02USD 4,448SEC filing ↗
2026-09-11Lu PengSale (S)Common Stock15,000USD 40.13USD 601,950SEC filing ↗
2026-09-11Lu PengOption exercise / conversion (M)Common Stock15,000USD 2.59USD 38,850SEC filing ↗
2026-09-11Lu PengTax withholding (F)Common Stock109USD 37.51USD 4,089SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerPHVS
CIK0001830487
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history126 transaction lines from 2026-04-01 to 2026-10-12
0 P purchase lines · 68 S sale lines · 58 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.